AntibodyLimited DatastaleGeneMedicine Co., Ltd.Phase 2
Part C (GM103 and Pembrolizumab, GM103 and Pembrolizumab (Part C))
Head and Neck Cancer; Malignant Melanoma · Head and Neck Cancer
#HeadandNeckCancer#Antibody#Phase2#monoclonal-antibody#MalignantMelanoma+1
Trials 1Status Recruiting